Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Eescula

Known as: Rescula 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The changes in intraocular pressure (IOP) and pupil size (PS) after instillations of 0.15% unoprostone isopropyl (Rescula… Expand
2004
2004
PURPOSE To investigate the effects of antiglaucoma eyedrops and vehicles on the proliferation of human corneal epithelial cells… Expand
2002
2002
PURPOSE To compare, in paired eyes of open-angle glaucoma patients and glaucoma suspects, hydrodynamic and visual changes after 1… Expand
2002
2002
PURPOSE To investigate the long-term effect of 0.12% isopropyl unoprostone (Rescula) on microcirculation in the human ocular… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2001
Highly Cited
2001
PURPOSE This study was performed to clarify the possible mechanism behind the ocular hypotensive effect of unoprostone isopropyl… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2000
2000
Rescula (0.12% unoprostone isopropyl) is the first docosanoid compound approved for treatment of glaucoma in humans. It is… Expand
  • figure 1
  • figure 2
2000
2000
PURPOSE To study the long-term effect of topically applied 0.12% isopropyl unoprostone (unoprostone, Rescula) on microcirculation… Expand
Highly Cited
1998
Highly Cited
1998
Latanoprost (PhXA41, Xalatan) and isopropyl unoprostone (UF-021, unoprostone, Rescula) two new prostanoid derivatives, have been… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 1
1997
1997
The effect of topically applied 0.12% isopropyl unoprostone (unoprostone, Rescula) on the circulation of optic nerve head (ONH… Expand
Highly Cited
1993
Highly Cited
1993
A double-masked comparative clinical study of UF-021 (Rescula), a unique prostaglandin-related compound, was carried out at 18… Expand